What causes vitreomacular traction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Vitreomacular Traction

Vitreomacular traction occurs when the posterior vitreous cortex incompletely separates from the retina during posterior vitreous detachment (PVD), remaining abnormally adherent to the macula while the surrounding vitreous detaches, creating tractional forces on the fovea. 1

Primary Pathophysiologic Mechanism

The fundamental cause is incomplete or anomalous posterior vitreous detachment 1:

  • The vitreous is most firmly attached at three anatomical sites: the vitreous base, optic nerve head, and macula 1
  • During normal PVD evolution over years, the posterior vitreous initially partially detaches but remains attached within the macular region 1
  • Eventually, complete detachment should occur when vitreous separates from the macula and finally from the optic nerve head 1
  • VMT develops when the perimacular vitreous continues to separate from the posterior retina yet remains adherent to a region near the center of the macula 1

Unknown Underlying Mechanism

The pathologic mechanism responsible for abnormal adhesion within the macula that leads to VMT remains unclear 1:

  • Why certain eyes develop persistent macular adhesion during PVD while others achieve complete separation is not well understood 1
  • The combination of focal macular attachment with surrounding vitreous separation creates the tractional forces 1

Age-Related Risk Factors

VMT is fundamentally an age-related condition tied to the natural evolution of PVD 1, 2:

  • PVD most commonly occurs between ages 45-65 years 2
  • VMT prevalence increases significantly with advancing age, affecting 0.4% to 2.0% of U.S. adults over age 63 1, 2
  • Peak prevalence occurs in the 7th and 8th decades of life 2
  • The condition is relatively uncommon before age 50 2

Secondary Causes and Associated Conditions

While most VMT is idiopathic, certain conditions may contribute 3, 4:

  • Exudative age-related macular degeneration: High coincidence between VMT and choroidal neovascularization has been documented 3
  • Anti-VEGF therapy: Rare cases of VMT formation during anti-VEGF treatment have been reported, potentially due to VEGF inhibition inducing fibrosis in eyes with adherent vitreous cortex 4
  • Diabetic retinopathy: VMT can occur in the context of diabetic macular edema 4

Clinical Consequences of the Traction

The persistent macular attachment with surrounding separation creates pathologic changes 1:

  • Macular thickening and distortion 1
  • Intraretinal cystoid changes 1
  • Subretinal fluid accumulation 1
  • Potential tractional macular detachment 1
  • Progression to macular hole formation 5, 6

Important Clinical Caveats

Distinguish VMT from normal vitreomacular adhesion (VMA): VMA represents physiological attachment of posterior cortical vitreous to the macula with completely preserved foveal depression and no tractional changes, whereas VMT involves pathological structural alterations 1, 6

Vitreopapillary traction can occur when raised edges of adherent vitreous are seen around the optic nerve head, which can be confused with papilledema 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Prevalence of Vitreomacular Traction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Vitreomacular Traction Following Anti-VEGF Therapy - Two Cases].

Klinische Monatsblatter fur Augenheilkunde, 2019

Research

Vitreomacular traction - a review.

Eye (London, England), 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.